Armata Pharmaceuticals Files 8-K on Shareholder Vote Matters

Ticker: ARMP · Form: 8-K · Filed: Jun 13, 2025 · CIK: 921114

Armata Pharmaceuticals, INC. 8-K Filing Summary
FieldDetail
CompanyArmata Pharmaceuticals, INC. (ARMP)
Form Type8-K
Filed DateJun 13, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: corporate-governance, shareholder-vote, sec-filing

TL;DR

Armata Pharma filed an 8-K on shareholder votes. Keep an eye on governance.

AI Summary

Armata Pharmaceuticals, Inc. filed an 8-K on June 13, 2025, reporting on matters submitted to a vote of security holders as of June 12, 2025. The filing details the company's corporate structure and operational information, including its principal executive offices in Los Angeles, California.

Why It Matters

This filing provides an update on corporate governance and shareholder decisions for Armata Pharmaceuticals, which is crucial for investors to understand the company's direction and management.

Risk Assessment

Risk Level: low — The filing is a routine corporate disclosure regarding shareholder votes and does not appear to contain significant new financial or operational risks.

Key Players & Entities

FAQ

What specific matters were submitted to a vote of Armata Pharmaceuticals' security holders?

The filing states that the report is pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and concerns 'Submission of Matters to a Vote of Security Holders,' but the specific details of the matters voted upon are not provided in this excerpt.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing was on June 12, 2025.

What is Armata Pharmaceuticals' principal executive office address?

Armata Pharmaceuticals' principal executive offices are located at 5005 McConnell Avenue, Los Angeles, California, 90066.

What is Armata Pharmaceuticals' IRS Employer Identification Number?

Armata Pharmaceuticals' IRS Employer Identification Number is 91-1549568.

What is the SEC file number for Armata Pharmaceuticals?

The SEC file number for Armata Pharmaceuticals is 001-37544.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on June 13, 2025 regarding Armata Pharmaceuticals, Inc. (ARMP).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing